GMP Biologics
GMP Biologics Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
GMP Biologics Market Size and Growth
The GMP Biologics market is witnessing robust growth, driven by increasing demand for biologics and stricter regulatory requirements. The global market size is projected to reach approximately USD 6.5 billion by 2028, with significant expansion in biomanufacturing capabilities and investments in technology enhancing production efficiency and compliance in biopharmaceutical sectors. Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Creative Diagnostics
◍ Fisher Bioservices(Thermo Fisher Scientific)
◍ Polpharma Biologics
◍ Intertek
◍ HemaCare
◍ AGC
The GMP biologics market features companies like Creative Diagnostics, Thermo Fisher Scientific, Polpharma Biologics, Intertek, HemaCare, and AGC, which provide essential biomanufacturing services. These firms contribute to the market's growth through innovative solutions, state-of-the-art facilities, and quality assurance, enhancing production capabilities and compliance with regulatory standards. Sales revenue: Thermo Fisher: $40 billion (2022).
Request Sample Report
Market Segmentation
By Application
Hospitals
Clinics
Others
Request Sample Report
By Product
Monoclonal Antibodies
Polyclonal Antibody
$ 53.60 Million
Request Sample Report
